Maruzen Company Limited
USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F41B (Weapons FOR Projecting Missiles Without USE OF Explosive OR Combustible Propellant CHARGE; Weapons NOT Otherwise Provided FOR).
The verdict
According to USPTO PatentsView, Maruzen ranks #24,756 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.
- #24,756
- of 49,997 US assignees by volume
- 6th percentile
- by Innovation Score (19.7/100)
- 8.3
- avg claims per patent
- -62%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R24756 · Foreign Corporation #24,756 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #24,756/49,997
- PHOTO-FINISH Maia Pharmaceuticals
- CPC-NARROW F41B · 3 areas
- INNOV-LOW 19.7/100
- CLAIMS-PAR 8.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -62% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Maia Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Maruzen’s 19.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Maruzen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Maruzen · this assignee 20
Maruzen · this assignee
20 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Maruzen's Innovation Score is 19.7/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Maruzen?
Each dot is one of Maruzen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maruzen’s own 8.3 claims/patent is ABOVE the 7.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Maruzen's grants concentrate
Maruzen Company Limited is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under F41B (Weapons FOR Projecting Missiles Without USE OF Explosive OR Combustible Propellant CHARGE; Weapons NOT Otherwise Provided FOR). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Maruzen sits between Maia Pharmaceuticals, Inc. and Maxine M. Thompson Trust.
Who files at Maruzen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Maia Pharmaceutic…
Maia Pharmaceuticals, Inc.
11 patents
- Maintech
Maintech Co., Ltd.
11 patents
- Manta Sleep
Manta Sleep LLC
11 patents
- Markwest Energy P…
Markwest Energy Partners, L.P.
11 patents
- Masarykova Univer…
Masarykova Univerzita
11 patents
- Massachusetts Gen…
Massachusetts General Hospital
11 patents
- Mattur Holdings
Mattur Holdings, Inc.
11 patents
- Maxine M Thompson…
Maxine M. Thompson Trust
11 patents
- Maruzen ◀
Maruzen Company Limited
11 patents
What this shows Maruzen holds 11 patents at rank #24,731, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Maruzen
By rank, the assignees closest to #24,731 in granted patent volume.
- Maia Pharmaceuticals, Inc. #24,727 · 11 patents
- Maintech Co., Ltd. #24,728 · 11 patents
- Manta Sleep LLC #24,729 · 11 patents
- Markwest Energy Partners, L.P. #24,730 · 11 patents
- Masarykova Univerzita #24,732 · 11 patents
- Massachusetts General Hospital #24,733 · 11 patents
- Mattur Holdings, Inc. #24,734 · 11 patents
- Maxine M. Thompson Trust #24,735 · 11 patents
Leaders in F41B (Weapons FOR Projecting Missiles Without USE OF Explosive…)
Other assignees with the most granted patents in Maruzen's primary technology class.
Maruzen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 6th percentile higher than 6% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 1 | 9.1% |
| 2017 | 4 | 36.4% |
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
Which technologies does Maruzen Company Limited patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Maruzen Company Limited's patent record in context - here's where to go next.
- Maruzen Company Limited's lead technology class is F41B (Weapons FOR Projecting Missiles Without USE OF Explosive OR Combustible Propellant CHARGE; Weapons NOT Otherwise Provided FOR), 100% of its portfolio - see every assignee active in that class. Explore F41B
- Ranked #24,756 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Maruzen Company Limited against Maia Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 19.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.